How ALTEN’s Life Sciences Division is Leading the way in Market Innovation
In the ever-changing landscape of life sciences, maintaining a competitive edge requires unwavering commitment to innovation.
Training and upskilling are part of our genes
It’s not enough to follow trends: you have to anticipate them, and to do that you need to bring together the best specialists.
When simple solutions require complex means
The life sciences market is constantly evolving, with technological, regulatory, and economic pressures driving everchanging trends.
AI as a solution for Healthcare (SDG)
The current healthcare landscape is shaped by AI’s potential to enhance diagnosis, treatments, and remote care.
Computers under examination
In the era of Manufacturing 4.0, the life sciences industry faces unprecedented challenges in validating computerised systems.
In an era of rapid technological advancement
Recent health crises have emphasised the need for agility in pharmaceutical development, where speed and efficiency are paramount.
Interview with Pierre Bonhomme
ALTEN is in a privileged position: both as a player in major projects in engineering, manufacturing customer services, digital transformation, and IT.
Cybersecurity: a moving target
The past decade has seen a resurgence of interest in the space sector and the technologies it embraces.
Beyond boundaries
Business in first quarter 2022: +31.3%
ORGANIC GROWTH REMAINS STRONG: +20.7% 3 ACQUISITIONS OVERSEAS BUSINESS AT THE END OF MARCH 2022: +31.3%The dynamic growth of last…
2021 full‐year results
SUSTAINED ORGANIC GROWTH: +12.9% SHARP INCREASE OF OPERATIONAL MARGIN ON ACTIVITY: +125% (10.9% OF REVENUE) 7 ACQUISITIONS IN FRANCE AND…
Business at the end of December 2021: +25,4%
SUSTAINED ORGANIC GROWTH: +12.9% 7 ACQUISITIONS IN FRANCE AND OVERSEAS BUSINESS IN 2021: +25.4%Although 2020 was impacted by the Health…
ALTEN experts decipher industry and digital trends.